SCHEMBL23947456

SCHEMBL23947456

c1ccc(-c2nc(-c3ccc4c(c3)oc3ccccc34)nc(-c3ccc4oc5cccc(-c6cccc7c8ccccc8n(-c8ccccc8)c67)c5c4c3)n2)cc1

nearest known ligand 0.39

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.33
ATM Q13315 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
SIRT2 Q8IXJ6 1/20 0.32
SIRT1 Q96EB6 1/20 0.32
PTGER4 P35408 2/20 0.32
CHEK2 O96017 1/20 0.32
LMNA P02545 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
PLA2G2A P14555 2/20 0.31
PLA2G4A P47712 2/20 0.31
PLA2G10 O15496 1/20 0.31
PRKDC P78527 1/20 0.31
AHR P35869 1/20 0.30
CA12 O43570 1/20 0.30
CA9 Q16790 1/20 0.30
DUSP3 P51452 1/20 0.30
ALOX5 P09917 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23947275 0.97 SIRT2 (0.34) KDM4EATML3MBTL1SIRT2SIRT1
SCHEMBL23947345 0.96 KDM4E (0.35) KDM4EATML3MBTL1SIRT2SIRT1
SCHEMBL23947434 0.96 SIRT2 (0.35) KDM4EATML3MBTL1SIRT2SIRT1
SCHEMBL22257904 0.96 KDM4E (0.36) KDM4EATML3MBTL1SIRT2SIRT1
SCHEMBL26168503 0.94 KDM4E (0.32) KDM4EATML3MBTL1SIRT2SIRT1
SCHEMBL22257993 0.94 KDM4E (0.36) KDM4EATML3MBTL1LMNASMN1; SMN2
SCHEMBL26169003 0.93 PRKDC (0.32) KDM4EATML3MBTL1SIRT2SIRT1
SCHEMBL23947435 0.93 KDM4E (0.34) KDM4EATML3MBTL1SIRT2SIRT1
SCHEMBL23947839 0.93 KDM4E (0.34) KDM4EATML3MBTL1SIRT2SIRT1
SCHEMBL26192776 0.93 KDM4E (0.35) KDM4EATML3MBTL1LMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11873297-B2 Compound and organic light emitting device comprising the same LG CHEM, LTD. (KR) 2024-01-16 US disclosed
US-11873297-B2 Compound and organic light emitting device comprising the same LG CHEM, LTD. (KR) 2024-01-16 US disclosed
US-20210323948-A1 NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME LG CHEM, LTD. (KR) 2021-10-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210323948-A1 NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME CCNL2, UBE2L3, OPRL1 KDM4E 3842/4885ATM 2218/4885L3MBTL1 94/4885
US-11873297-B2 Compound and organic light emitting device comprising the same CCNL2, UBE2L3, ARL1 KDM4E 3695/4885ATM 2154/4885L3MBTL1 83/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.